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Background: Obesity and serum C-reactive protein (CRP) (a sensitive marker of inflammatory activity) are
associated with most chronic diseases. Abdominal adiposity along with age is the strongest determinant of baseline
CRP levels in healthy subjects. The mechanism of the association of serum CRP with disease is uncertain. We
hypothesized that baseline serum CRP is a marker of inflammatory responsiveness to injury and that abdominal
adiposity is the main determinant of this responsiveness. We studied the effect of abdominal adiposity, age and
other environmental risk factors for chronic disease on the CRP response to a standardised surgical insult, unilateral
hernia repair to not only test this hypothesis but to inform the factors which must be taken into account when
assessing systemic inflammatory responses to surgery.
Methods: 102 male subjects aged 24-94 underwent unilateral hernia repair by a single operator. CRP was measured
at 0, 6, 24 and 48 hrs. Response was defined as the peak CRP adjusted for baseline CRP.
Results: Age and waist:hip ratio (WHR) were associated both with basal CRP and CRP response with similar effect
sizes after adjustment for a wide-range of covariates. The adjusted proportional difference in CRP response per 10%
increase in WHR was 1.50 (1.17-1.91) p = 0.0014 and 1.15(1.00-1.31) p = 0.05 per decade increase in age. There was
no evidence of important effects of other environmental cardiovascular risk factors on CRP response.
Conclusion: Waist:hip ratio and age need to be considered when studying the inflammatory response to surgery.
The finding that age and waist:hip ratio influence baseline and post-operative CRP levels to a similar extent
suggests that baseline CRP is a measure of inflammatory responsiveness to casual stimuli and that higher age and
obesity modulate the generic excitability of the inflammatory system leading to both higher baseline CRP and
higher CRP response to surgery. The mechanism for the association of baseline CRP and waist:hip ratio to chronic
disease outcomes could be through this increase in inflammatory system excitability.
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Obesity is associated with an increased risk of develo-
ping and mortality from many chronic diseases including
atherosclerosis, most forms of epithelial cancer and
other non-vascular diseases [1-3]. Likewise serum levels
of the marker of acute inflammation C-reactive protein
(CRP) in otherwise healthy subjects are associated with a
similar range of diseases and outcomes but also include* Correspondence: m.mendall@btinternet.com
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reproduction in any medium, provided the orsmoking related respiratory disease [4]. Obesity and in
particular abdominal adiposity along with age are the
strongest determinants of baseline CRP levels in healthy
subjects with other environmental and behavioural risk
factors for disease having a weaker but measureable
effect on levels [5-8].
As yet the mechanism linking circulating levels of CRP
within the reference range to the pathogenesis of athe-
rosclerosis and other chronic disease is uncertain. CRP
itself is unlikely to be of pathogenic significance [9,10].
It has been proposed variously that levels reflect
increases in inflammation which change cardiovasculartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mote disease or that CRP levels are an epiphenomenon
of tissue stress due to the injury which mediates disease
[7,11,12].
We postulated that basal CRP levels are in fact a mea-
sure of the individual’s inflammatory responsiveness to the
environment. Hence the explanation for the association
between both obesity and CRP with a range of chronic
disease outcomes could be because of the effect of obesity
on an individual’s inflammatory responsiveness. These
inflammatory mechanisms mediate the effect of the envi-
ronment on chronic disease a various disease locations eg
the blood vessel wall in atherosclerosis secondary to the
effects of hypertension and various organ locations in
cancer.
Host characteristics which affect the inflammatory
response to injury have been little studied, although in a
small study the inflammatory response was reported to
be higher in obese subjects undergoing laparoscopic
cholecystectomy [13]. One way to do this would be
study the response to an easily standardisable insult
administered to otherwise healthy subjects. We postu-
lated that abdominal adiposity, the major determinant
along with age of basal CRP levels would be associated
with increased response.
Our primary aim was to determine whether abdominal
adiposity was related to post insult CRP levels following
a standardised surgical insult. The secondary aim was to
determine what effect other environmental risk factors
for chronic disease had on the CRP response. The stan-
dardised insult we chose was unilateral hernia repair.
Methods
Following approval by the local research and ethics com-
mittee, and subject to informed consent, patients were
recruited consequently. All male patients aged greater
than 16 undergoing unilateral primary open inguinal
hernia repair by a single operator between December 2007
and March 2009 were included. All subjects underwent a
general anaesthetic. Subjects were excluded if they had
diabetes, chronic renal or cardiac failure, on long term
steroid or NSAID therapy (apart from cardioprotective
aspirin), if they were otherwise unfit for surgery or if they
were unable to give informed consent.
Base line measurements including heart rate, blood
pressure, height, weight, waist and hip circumferences
were recorded on the day of surgery. Waist measurements
were taken at the midpoint between the lower ribs and
iliac crest and hip measurements as the maximum
circumference between the waist and upper thigh. Patient
information including age, race, past medical history, drug
history, smoking habits, physical activity and occupational
history was collected at the time of recruitment. Drug
history was taken for any medication consumed in theprevious week (NSAIDs and anti-hypertensive medica-
tion). Subjects were said to be hypertensive if currently
taking anti-hypertensive medication. Post operative data
were also collected regarding wound infection and the
presence of systemic inflammatory response syndrome
but no cases of either were observed.
All were operated on by a single senior surgeon using
Lichtenstein mesh repair with proline. A standardized
general anaesthetic technique was used. All patients
received 20 ml of 0.25% chirocaine wound infiltration; a
standardized oral analgesic (Co-codamol) was given to
patients on discharge. All operations were performed in
the morning and patients were discharged at 6 hours
post surgery. The baseline blood test was collected on
arrival for the procedure and the 6 hour specimen soon
before discharge home. The 24 and 48 hr specimens
were obtained by visiting the patients in their home the
morning of the following 2 days to within +/- 1.5 hour
of the time of their operation with no requirement for
fasting.
Serum C-reactive protein was determined using a high
sensitivity near infrared particle immunoassay rate method
on a LX-20pro (Beckman Coulter Inc, High Wycombe,
UK) according to the manufacturer’s instructions. The
sample is incubated with an anti-CRP antibody coated to a
micro particle to form a [CRP (sample)-antibody complex]
causing turbidity in the reaction. The change in absor-
bance is measured specrophotometrically at 940 nm and
is directly proportional to the concentration of CRP.
The assay has a measuring range of 0.2 – 80 mg/L.
The functional sensitivity (20% coefficient of variation)
was <0.18 mg/L. The total assay precision as reported by
the manufacture was 3.4-5.1% at 0.7 – 77.5 mg/L. The
reported 95th centile reference interval based on 551
healthy non smoking adults provided by the manufacturer
(>18 years of age) was 0 to 7.48 mg/L.
Statistical methods
CRP response to surgery was defined as the postopera-
tive CRP value adjusted for the baseline CRP in ANOVA
models or regression models when only continuous or 2
level explanatory variables were included. Thus individ-
ual CRP responses correspond to the model adjusted
postoperative CRP values as if each patient had the same
mean preoperative CRP value. As the postoperative CRP
values did not always peak at 48 hours, sometimes earl-
ier (especially in younger patients) the highest of the 6,
24 and 48 hour values, the peak values were considered
as the primary outcome in statistical modelling. If any
post-operative values were missing, the highest of the
timepoints for which there was data was taken. A se-
condary measure of response was also included consis-
ting of the difference between peak and baseline CRP
log transformed.
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ANOVA and linear regression models: age at surgery, CRP
before surgery, peak CRP after surgery, ethnic group
(Caucasian, Afro-carribean, Asian or other), exercise
(binary, none or exercise less than twice a week versus any
exercise twice a week or more), smoking (current, ex and
never), waist:hip ratio, occupation (manual, non-manual,
retired), duration of surgery (minutes), wound length (cm).
Each interval-scale variable was considered either on its
original scale (age, wound length, duration of surgery) or
after logarithmatic transformation (waist:hip. C-reactive
protein at each time point ) to normalise the distribution.
Not more than one of the obesity markers BMI, or waist:
hip ratio were included in the models. Interactions were
not considered.
Two multivariate models are presented: firstly a model
including all explanatory variables and secondly a model
including only waist:hip, age and duration of surgery.
Finally, to allay any fears over confounding, the relation-
ship of waist:hip ratio to the other explanatory variables is
presented.
Statvew SE was used for the statistical analysis.
Sample size calculations
Based on initial pilot study in 40 subjects, the corre-
lation coefficient for waist hip with log10 of the mean
CRP at 24 hours was 0.375. The standard deviation of
waist hip ratio was estimated to be 0.08 and the standard
deviation of the log of the mean CRP at 24 and 48 hrs
would be 1.13 as would the standard deviation of the
maximum CRP at either 24 or 48 hrs. A sample size of
90 was calculated as giving a power of 80% to detect a
1.8 fold ratio of CRP across the interquartile range ie the
CRP at the 75th quartile would be 1.8 times that of the
25th centile.
Results
Table 1 shows the baseline characteristics of the 102
subjects, CRP levels at different time points together
with operative details. There were no cases of post-
operative wound infection. Table 2 displays the univari-
ate analysis of the association of baseline characteristics
with baseline CRP, peak CRP post surgery and peak
CRP-baseline CRP. Figure 1 shows the association of
waist:hip ratio with post operative CRP by wasit:hip ratio
tertile at different time points. Significant associations
existed between age, waist circumference and waist:hip
ratio with baseline, post operative CRP and change in
CRP. BMI demonstrated associations in the expected
directions but these were not significant. Duration of
surgery was associated with all three CRP measures,
although the relationship with baseline CRP was of bor-
derline statistical significance. Wound length likewise
was associated with baseline and peak CRP but notadditive change. Smoking status and social class were
associated with baseline CRP but not post-operative
CRP. However social class was associated with difference
in CRP. Exercise history demonstrated associations in
the expected direction for baseline CRP but this was not
significant. Anti-hypertensive treatment was associated
with post operative CRP and change in CRP
Table 3 displays the multivariate analysis of the associa-
tions of baseline and peak CRP and additive change in
CRP including all the baseline predictor variables with the
exception of BMI, and waist circumference. Strikingly,
waist:hip ratio was related to all CRP measures. Baseline
CRP was related to peak CRP but not the additive change.
The magnitude of the effect was similar for baseline, peak
and additive change in CRP. Although age demonstrated a
similar magnitue of effect for the three CRP measures, the
effect was only significant for peak CRP. Duration of
surgery was associated strongly with peak CRP and addi-
tive change, but not with baseline CRP although the effect
was of similar magnitude. There was no independent
association of wound length or ethnic group with the
exception of a low baseline CRP in the small group of
subjects from the ’other’ ethnic group. There were no
significant associations of social class with any of the three
measures of CRP, nor of being on anti-hypertensive
medication.
When waist:hip ratio and waist circumference were both
put into the full multivariate model, waist:hip ratio
retained its statistical significance and the magnitude of
the effect was little diminished- 1.40(1.00-1.96) p = 0.05,
whereas the effect of waist circumference was abolished-
1.07 (0.81-1.43) NS.
Table 4 shows the effect sizes of age, baseline CRP,
waist:hip ratio, duration of surgery and wound length
mutually adjusted in a model restricted to the indepen-
dent predictors with the exception of wound length
which was included because of it’s importance as a
potential confounder. As all these variables are continu-
ous the model was run using multiple regression.
Duration of surgery and wound length were not
included in the model of baseline CRP. The magnitude
of the effect of waist:hip on baseline, adjusted peak and
difference in CRP is little changed by adjustment for the
additional factors and also striking is the similarity of
the magnitude of the effects on all three measures of
CRP. This is illustrated in Figure 2 where it is demon-
strated that the scatter plots for waist:hip ratio versus
CRP at baseline and peak have parallel regression lines
and that scatter of points seen at baseline is reduced as
the dominant influence of surgery on levels manifests.
Table 5 shows the relationship of waist;hip ratio to base-
line characteristics. The only important relationships were
with age and manual social class as would be expected.
There was no association with duration of surgery, but
Table 1 Baseline characteristics and c-reactive protein at different time points of study subjects
Characteristics
Age (mean, sd, range) 60.6 (14.4, 24-90)
Ethnic Group: n, %
White Caucasian 77 (76%)







Anti-hypertensive medication 21 (20%)
Waist:hip ratio (mean, sd,range) 0.945 (0.071, 0.79-1.14)
Waist circumference (cm) (mena, sd, range) 94.9 (9.54, 74-127)
BMI (mean, sd, range) 25.7 (3.09, 17.9-37)
Exercise
<2 x /week 68 (67%)





Wound length cm mean, sem, range 8.43 (0.84, 7-10)
Duration of surgery mins 18.2 (5.54, 8-40)
Mean, sd, range
Serum C-reactive protein, geom. Mean, median, range) at baseline n = 102 1.28 (1.34, 0.1-92.4)
Serum C-reactive protein, geom. Mean, median, range) at 6 hrs n = 95 1.22 (1.30, 0.1-79.8)
Serum C-reactive protein, geom. Mean, median, range) at 24 hrs n = 98 13.7 (17.6, 0.8-120)
Serum C-reactive protein, geom. Mean, median, range) at 48 hrs n = 97 20.0 (27.4, 0.1-121.4)
Serum C-reactive protein, geom. Mean, median, range) peak n = 102 24.0 (28.4, 0.1-121.4)
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expected.Discussion
This is the first study to examine the effect of abdominal
adiposity and other environmental risk factors on the
inflammatory response to injury as indicated by serum
CRP. We primarily defined CRP response to surgery as
the logarithm of postoperative peak CRP adjusted for
preoperative CRP level. We also used a secondary defi-
nition of the logarithm of the additive change in CRP
pre and post surgery. These two measures gave similar
results. CRP response was higher with higher waist:hip
ratio, increasing age and longer duration of surgery. The
relation to waist:hip ratio was continuous with no appa-
rent threshold effect.Although some of the established risk factors for athe-
rosclerosis and other chronic diseases such as cigarette
smoking, ethnic group and social class exhibited associa-
tions with baseline CRP (for exercise there was a trend in
the expected direction) in univariate analysis, there were
no important effects on response after adjustment for
other factors. The study was not designed to explore these
effects and may have been too small to detect them or
alternatively they may not have been present. The reduc-
tion in the magnitude of the effects supports the latter.
This is a relatively small study, but the magnitude of
the effects we observed for waist:hip ratio leave little
doubt as to the fact that they are true findings. We
chose hernia repair as it is easily standardised, easy to
grade the insult, and is associated with a demonstrable
inflammatory response. It is unlikely that the exagge-
rated response in subjects with a high waist:hip ratio






Difference in peak CRP peak and baseline
(proportional change)
Baseline CRP (per 10 fold increase) 2.44 (1.76-3.38) p < 0.0001 1.23 (0.86-1.76) ns
Waist:hip ratio (per 10% increase) 1.70 (1.22-2.37) p = 0.0022 1.86 (1.44-2.40) p < 0.0001 1.52 (1.17-1.98) p = 0.0019
BMI(per unit change) 1.06 (0.97-1.16) p = 0.16 1.05 (0.97-1.12) p = 0.24 1.06 (0.99-1.14) p = 0.1
Waist circumference
(per 10 cm increase)
1.68 (1.28- 2.20) p = 0.0002 1.60 (1.29- 1.98) 1.43 (1.15- 1.77) p = 0.0015
P < 0.0001
Weight (per 10 kg increase) 1.21 (0.95-1.52) 1.14 (0.95-1.39) 1.16 (0.97-1.39) p = 0.09
Age (per decade) 1.38 (1.15-1.66) p = 0.0006 1.32 (1.14-1.52) p = 0.0003 1.18 (1.02-1.37) p = 0.02
Duration of surgery (per minute) 1.05 (1.01-1.11) p = 0.04 1.06 (1.02-1.10) p = 0.003 1.05 (1.02-1.09) p = 0.007
Wound length (per cm) 1.46 (1.06-2.00) p = 0.02 1.33 (1.03-1.73) p = 0.03 1.28 (0.99-1.65) p = 0.06
*Ethnic Group: n, %
White Caucasian 1.46 (1.00-2.63) 1.38 (0.91- 1.51) 1.17 (0.78- 1.74)
Afro Carib 1.27 (0.66- 2.43) 0.83 (0.55- 1.50) 0.87 (0.50- 1.73)
Asian 1.67 (0.73- 3.84) 1.15 (0.55- 2.40) 1.12 (0.54- 2.30)
Other (ref) 0.29 P = 0.06 0.75 0.88
*Smoking status (%)
Current (reference) 0.80 0.87 0.93 (0.70-1.24)
Ex 1.66 (1,12- 2.45) 1.30 (0.95- 1,78) 1.13 (0.82- 1.56)
Never 0.76 (0.53- 1.08) P = 0.04 0.88 (0.66- 1.17) 0.95
Exercise
<2 × /week (reference)
2 + ×/week 0.64 (0.36-1.13) p = 0.12 0.95 (0.59-1.52) 1.14 (0.72-1.79)
*Occupation
Manual (reference) 0.73 (0.47- 1.14) 0.68 (0.48- 0.96) 0.69 (0.48- 0.99)
Non-manual 0.80 (0.54- 1.17) 1.06 (0.78- 1.43) 1.18 (0.87- 1.60)
retired 1.73 p = 0.007 1.39 P = 0.1 1.23 P = 0.002
Anti-hypertensive medication 1.63 (0.86-3.10) 1.91 (1.13-2.61) p = 0.02 1.82 (1,10-2.61) P = 0.02
CRP was log transformed for the purposes of analysis of baseline CRP and post-operative CRP and the absolute difference in pre-op and post-operative CRP was
log transformed after adding 1 to the difference.
*ANOVA coefficients, statistical significance determined by ANOVA.
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technique, as the association was independent of dur-
ation of surgery or wound length even although the
latter was associated with waist:hip ratio. We cannot
entirely discount the possibility that the increased
response with waist:hip ratio was due to increased da-
mage to subcutaneous adipose tissue due to a greater
depth of incision. However if this were the case, it would
be expected that wound length would be independently
associated with inflammatory response and that it would
confound the association with waist:hip ratio which it
did not. It seems unlikely that wound depth which we
did not measure would vary inversely with wound
length. Importantly, there was no association of the du-
ration of surgery with waist:hip ratio. Furthermore, the
association of waist:hip ratios with CRP response wascontinuous throughout the range of ages and waist:hip
ratios with no evidence of a threshold for the effect.
Likewise it seems unlikely that differences in CRP
response could be explained by post-operative infection
being more common as waist:hip ratio rises. We did not
find any instances of post-operative infection and if lung
infection caused by atelectasis related to the anaesthetic
were responsible, a higher post-operative response in
smokers would have been expected. It seems most likely
therefore that waist:hip ratio is associated with an
increased CRP responsiveness to injury through mecha-
nisms independent of the degree of tissue damage or pro-
cedure related infection.
The C-reactive protein response to inguinal hernia
repair has been described on numerous occasions, but
with the goal of comparing operative technique rather





Difference in peak CRP peak and baseline
(proportional difference)
Baseline CRP (per 10 fold increase) 1.77 (1.25-2.52) P = 0.002 0.85 (0.58-1.26)
Waist:hip ratio (per 10% increase) 1.43 (1.02- 2.01) p = 0.04 1.46 (1.14-1,88) P = 0.002 1.41 (1.06- 1.59) P = 0.02
Age (per decade) 1.20 (0.81-1.56) 1.27 (1.00-1.62) p = 0.05 1.20 (0.92-1.57)
Duration of surgery (per minute) 1.05 (0.99-1.10) p = 0.06 1.05 (1.02-1.09) P = 0.007 1.06 (1.02-1.11) p = 0.004
Wound length (per cm) 1.17 (0.83-1.64) 0.94 (0.73-1.21) 1.07 (0.81-1.41)
Ethnic Group: n, %
White Caucasian 1.30 (0.77-2.20) 1.15 (0.78-1.69) 1.11 (0.71-1.71)
Afro Carib 1.52 (0.81-2.87) 0.88 (0.55-1.41) 0.99 (0.59-1.68)
Asian 1.91 (0.78-4.68) 1.04 (0.53-2.03) 1.26 (0.60-2.67)
Other (reference) 0.27 p = 0.04 0.96 0.72
Smoking status (%)
Current (reference) 0.97 0.96 0.96
Ex 1.17(0.47-1.38) 1.00 (0.75-1.33) 0.96 (0.70-1.33)
Never 0.89(0.62-1.26) 1.04 (0.81-1.35) 1.08 (0.81-1.45)
Exercise
<2 x /week (reference) 2 + x/week 0.80(0.47-1.38) 1.27 (0.86-1.89) 1.39 (0.89-2.17)
Occupation
Manual 0.96 (0.58-1.56) 0.90 (0.62-1.29) 0.84(0.56-1.26)
Non-manual 0.83 (0.54-1.26) 1.39 (1.02-1.89) 1.29(0.91-1.82)
Retired (reference) 1.27 0.81 0.93
Anti-hypertensive medication 1.12 (0.59-2.12) 1.34 (0.83-2.19) 1.47(0.91-2.40)
All predictors are mutually adjusted. The analysis was by ANOVA.
Figure 1 A box and whisker plot of the association of waist:hip ratio by tertile and CRP at different time points.
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Difference in peak CRP peak and baseline
(proportional difference)
Baseline CRP (per 10 fold increase) 1.72 (1.23-2.40) p = 0,002 0.86 (0.59-1.25)
Waist:hip ratio(per 10% increase) 1.46 (1.01-2.12) p = 0.04 1.53 (1.17-2.01) p = 0.002) 1.47 (1.08-1.98) p = 0.01
Age (per decade) 1.28 (1.05-1.56) p = 0.01 1.15 (1.00-1.33) p = 0.05 1.13 (0.96-1.32) p = 0.1
Duration of surgery (per minute) 1.05 (1.01-1.10) p = 0.03 1.05 (1.01-1.08) p = 0.007 1.06 (1.02-1.10) p = 0.005
Wound length (per cm) 1.10 (0.79-1.53) 0.99 (0.78-1.25) 1.08 (0.83-1.41)
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inflammatory response [14]. Future studies in this area
should take account of age and waist:hip ratio. They
should also take account of the length of incision and
more importantly the duration of surgery. One other
study has explored the relationship of obesity to the post
operative inflammatory response following laparoscopic
cholycystectomy and like the current study found it to
be exagerated with impaired anti-inflammatory cytokine
production. This study however was small with only 34
subjects, only compared obese and normal BMI subjects
and did not study other host characteristics which could
influence the inflammatory response [13].
We chose peak CRP adjusted for baseline CRP as the
measure of response. Similar findings were obtained
when the additive change in CRP was used. However the
better model fit was with the former. Whilst baseline
CRP was strongly associated with peak CRP, there was
no association with the additive change, suggesting that
regression to the mean is not an explanation for asso-
ciation of waist:hip ratio with the latter. For logistic and
resource reasons we did not measure CRP beyond
48 hrs and it is possible that we would have obtained
some higher peak values had we done so. However,
values beyond 48 hrs would have been more likely to be
influenced by factors other than the initial surgical insult
which it was our goal to measure the effect of.
The measure of adiposity most strongly related to CRP
response was waist:hip ratio, which is the best measure
of visceral adipose tissue, followed by waist circum-
ference with only a weak association with BMI. Had we
measured visceral adipose tissue more directly using CT
scanning, it is likely that we would have found an even
stronger association. The stronger association of waist:
hip ratio is in line with other studies assessing the asso-
ciation of adiposity with circulating inflammatory
markers and the metabolic syndrome [6,8]. Studies of
the association of adiposity with disease end points
however suggest that BMI may be the better marker [2],
but that waist:hip ratio has an additional effect inde-
pendent of BMI. BMI is the more imperfect measure of
abdominal adiposity but possibly a better measure of
total adiposity. It is also easier to measure than waist:hip
ratio in large field studies.It can be speculated that the finding that waist:hip
ratio and age influence baseline and post-injury CRP
levels with a very similar size of effect supports the
contention that baseline CRP is a measure of inflamma-
tory responsiveness to casual stimuli and that obesity
and higher age modulate the generic excitability of the
inflammatory system leading to both higher baseline
CRP and higher CRP response to surgery through simi-
lar mechanisms. The mechanism for the association of
baseline CRP and waist:hip ratio to cardiovascular disease
and other disease outcomes could be through this increase
in inflammatory system excitability leading to exaggerated
local inflammatory responses to environmental exposures,
specifically hypertension at the blood vessel wall in the
case of atherosclerosis, and various organ specific loca-
tions in cancer.
There are other possible explanations for the association
of basal CRP with risk of atherosclerosis rather than as an
indicator of immune responsiveness. The elevated CRP
could be the result of inflammation in response to sub-
clinical disease. This however is unlikely, as the relation-
ship of baseline CRP with many adverse outcomes does
not diminish with time from when it was measured [1].
Another interpretation is that the environmental factors
which cause disease through other mechanisms also acti-
vate inflammation. We cannot discount this possibility.
Finally it is possible that the inflammatory responses of
which CRP is a marker induce changes in conventional
risk factors such as lipids, insulin and blood sugar which
are related to insulin resistance as part of the metabolic
syndrome and that it is these which result in the adverse
consequences. Only one other study has addressed this
issue, the Rancho Bernado Study [15]. In this study,
adjustment for CRP attenuated the effect of the metabolic
syndrome by 35%, whereas adjustment of the effect of
CRP for the metabolic syndrome did not reduce the size
of effect. This suggests that the association between fea-
tures of the metabolic syndrome and atherosclerosis may
at least to an important degree be explained by its asso-
ciation with underlying inflammatory mechanisms.
As well as the relevance of our findings to the study of
the inflammatory response to surgery, atherosclerosis,
cancer and other chronic diseases, these findings would
explain the rather puzzling observation that obesity,
Figure 2 The regression lines for the association of waist:hip ratio with baseline and peak CRP.
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death from external causes and the higher rates of mor-
bidity in the obese from trauma, surgery and acute pan-
creatitis [16,17]. Furthermore it would explain the
higher rates of osteoarthritis in non weight bearingTable 5 Relation of waist:hip ratio to baseline risk factors.
Statistical testing for categorical variables was by ANOVA
and linear regression for continuous variables
Waist:hip ratio proportional change




Wound length (per cm) 1.47 (1.14- 1.88) p = 0.003
Ethnic Group: n, %
White Caucasian 0.81 (0.42- 1.58)
Afro Carib 0.44 (0.18- 1.07)







2 + ×/week v < 2× /week 0.85 (0.39- 1.84)
Occupation
Manual (reference) 1.66 (NS)
Non-manual 0.82 (0.49-1.40)
Retired 0.73 ( 0.40-1.33)joints in obese subjects [18]. Exaggerated inflammatory
responses could be damaging through a number of
mechanisms and could delay healing and resolution of
inflammation.Conclusions and future work
When comparing the invasiveness of surgical methods
using CRP levels, waist:hip ratio and age need to be taken
into consideration. Higher CRP levels could be due to
higher waist:hip ratios and age rather than the more inva-
sive procedure. The duration of surgery also needs to be
considered as an important factor.
It can also be speculated that WHR may modulate the
generic excitability of the inflammatory system leading
to higher baseline and higher CRP responses to injury
through similar but as yet to be determined mechan-
isms. This could increase the risk of atherosclerosis and
other chronic diseases in response to environmental
insults.
Larger studies are called for to assess other possible
determinants of inflammatory responses to injury such
as blood lipid levels, as well as the effect of drugs which
reduce risk of death from chronic disease such as statins
and aspirin. These drugs could possibly reduce the
risk associated with surgery. The effect of obesity
and other factors on the response of other cytokines
to standardised injury is also warranted. We propose
unilateral hernia repair as a useful model for study-
ing these effects.
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